| Issue Date | Title | Author(s) |
| 2013-03-01 | Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D<inf>3</inf> receptor knock-out mice following passive avoidance conditioning | D'Amico, AG; Castorina, A; Leggio, GM; Drago, F; D'Agata, V |
| 2016-05-01 | Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization | Gold, MJ; Hiebert, PR; Park, HY; Stefanowicz, D; Le, A; Starkey, MR; Deane, A; Brown, AC; Liu, G; Horvat, JC; Ibrahim, ZA; Sukkar, MB; Hansbro, PM; Carlsten, C; Vaneeden, S; Sin, DD; McNagny, KM; Knight, DA; Hirota, JA |
| 2019-02-07 | TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis | Collison, AM; Li, J; De Siqueira, AP; Lv, X; Toop, HD; Morris, JC; Starkey, MR; Hansbro, PM; Zhang, J; Mattes, J |
| 2002-08-01 | Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice | Sedger, LM; Glaccum, MB; Schuh, JCL; Kanaly, ST; Williamson, E; Kayagaki, N; Yun, T; Smolak, P; Le, T; Goodwin, R; Gliniak, B |
| 2010-06-15 | P2X<inf>7</inf> receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages | Lees, MP; Fuller, SJ; McLeod, R; Boulter, NR; Miller, CM; Zakrzewski, AM; Mui, EJ; Witola, WH; Coyne, JJ; Hargrave, AC; Jamieson, SE; Blackwell, JM; Wiley, JS; Smith, NC |
| 2011-01-10 | Interleukin-17 deficiency improves locomotor recovery and tissue sparing after spinal cord contusion injury in mice | Hill, F; Kim, CF; Gorrie, CA; Moalem-Taylor, G |
| 2012-06-19 | TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life | Beckett, EL; Phipps, S; Starkey, MR; Horvat, JC; Beagley, KW; Foster, PS; Hansbro, PM |
| 2018-03-01 | Tumor suppressor role of miR-503 | Gupta, G; Chellappan, DK; De Jesus Andreoli Pinto, T; Hansbro, PM; Bebawy, M; Dua, K |
| 2017-06 | In vivo effector functions of high-affinity mouse IgG receptor FcγRI in disease and therapy models. | Gillis, CM; Zenatti, PP; Mancardi, DA; Beutier, H; Fiette, L; Macdonald, LE; Murphy, AJ; Celli, S; Bousso, P; Jönsson, F; Bruhns, P |
| 2012-05-23 | M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection | Blumenthal, A; Nagalingam, G; Huch, JH; Walker, L; Guillemin, GJ; Smythe, GA; Ehrt, S; Britton, WJ; Saunders, BM |
